US Stock MarketDetailed Quotes

RXRX Recursion Pharmaceuticals

Watchlist

7.375
+0.285+4.02%

Trading Dec 4 13:18 ET

2.11BMarket Cap-4788P/E (TTM)

Recursion Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

18.78%-59.23M

-21.87%-82.22M

-39.53%-102.3M

-244.55%-287.78M

-65.54%-74.08M

-33.70%-72.92M

-9.48%-67.47M

-194.74%-73.32M

47.34%-83.52M

26.83%-44.75M

Net income from continuing operations

-3.04%-95.84M

-27.13%-97.54M

-39.87%-91.37M

-36.99%-328.07M

-61.75%-93M

-53.89%-93.02M

-17.03%-76.73M

-16.70%-65.33M

-28.42%-239.48M

11.46%-57.49M

Depreciation and amortization

-5.01%7.2M

61.79%8.97M

97.88%7.38M

107.57%24.4M

135.00%7.55M

153.53%7.58M

98.96%5.54M

34.73%3.73M

39.87%11.76M

43.74%3.21M

Other non cash items

4,900.00%8.5M

-95.41%93K

-29.29%1.91M

33.76%11.45M

168.88%6.55M

-90.41%170K

-8.20%2.03M

26.12%2.7M

108.93%8.56M

110.54%2.44M

Change In working capital

159.75%2.67M

-1.41%-10.26M

-49.36%-36.45M

-147.90%-50.26M

-1,775.21%-11.27M

42.54%-4.46M

-6.12%-10.12M

-119.87%-24.4M

34,387.91%104.92M

84.82%-601K

-Change in receivables

-362.56%-939K

190.42%736K

-228.08%-1.04M

-387,700.00%-7.76M

-215.25%-6.42M

-105.37%-203K

54.78%-814K

95.80%-317K

99.96%-2K

306.72%5.57M

-Change in payables and accrued expense

-47.78%4.39M

-10.45%4.26M

-88.89%-17.96M

392.53%8.44M

-50.65%4.78M

131.91%8.41M

207.30%4.76M

27.67%-9.51M

-88.63%1.71M

442.35%9.69M

-Change in other current liabilities

-87.52%-4.7M

12.47%-2.62M

-55.24%-3.79M

-38.71%-9.86M

12.41%-1.91M

-18.58%-2.51M

-93.79%-3M

-93.20%-2.44M

---7.11M

---2.18M

-Change in other working capital

138.55%3.92M

-14.19%-12.64M

-12.54%-13.66M

-137.23%-41.08M

43.58%-7.72M

22.16%-10.16M

-43.01%-11.07M

-108.38%-12.13M

1,203.20%110.32M

-447.00%-13.68M

Cash from discontinued investing activities

Operating cash flow

18.78%-59.23M

-21.87%-82.22M

-39.53%-102.3M

-244.55%-287.78M

-65.54%-74.08M

-33.70%-72.92M

-9.48%-67.47M

-194.74%-73.32M

47.34%-83.52M

26.83%-44.75M

Investing cash flow

Cash flow from continuing investing activities

-1,214.70%-4.56M

-103.70%-4.18M

-24.59%-6.65M

-105.29%-10.23M

68.82%-2.49M

-100.65%-347K

-141.56%-2.05M

-103.73%-5.34M

171.11%193.25M

84.73%-7.98M

Net PPE purchase and sale

-512.35%-4.56M

70.21%-1.18M

-28.56%-6.65M

67.74%-11.96M

74.09%-2.07M

90.98%-745K

75.92%-3.97M

-19.18%-5.18M

6.88%-37.06M

-78.74%-7.98M

Net intangibles purchase and sale

--0

---3M

--0

-99.00%-597K

---350K

72.67%-82K

--0

---165K

---300K

--0

Net business purchase and sale

--0

----

--1.84M

---71K

--0

----

--0

Net investment purchase and sale

----

-99.79%480K

--0

----

199.42%230.61M

--0

Cash from discontinued investing activities

Investing cash flow

-1,214.70%-4.56M

-103.70%-4.18M

-24.59%-6.65M

-105.29%-10.23M

68.82%-2.49M

-100.65%-347K

-141.56%-2.05M

-103.73%-5.34M

171.11%193.25M

84.73%-7.98M

Financing cash flow

Cash flow from continuing financing activities

-69.38%16.46M

6,848.03%263.12M

623.05%13.9M

-9.21%140.13M

-45.23%80.66M

2,200.60%53.77M

41.94%3.79M

-7.77%1.92M

-66.34%154.35M

3,779.24%147.26M

Net issuance payments of debt

-9,429.17%-2.29M

-8.33%-26K

-751.11%-766K

-2,917.39%-694K

-4.35%-24K

-9.09%-24K

99.30%-90K

-9.52%-23K

Net common stock issuance

-66.06%16.97M

--261.55M

--10.87M

-10.87%128.09M

-45.66%78.09M

--50M

--0

-68.95%143.71M

--143.71M

Proceeds from stock option exercised by employees

-53.00%1.78M

-57.96%1.6M

56.73%3.05M

19.41%12.81M

-8.63%3.26M

60.55%3.79M

41.67%3.81M

-7.60%1.95M

27.11%10.72M

-6.52%3.57M

Cash from discontinued financing activities

Financing cash flow

-69.38%16.46M

6,848.03%263.12M

623.05%13.9M

-9.21%140.13M

-45.23%80.66M

2,200.60%53.77M

41.94%3.79M

-7.77%1.92M

-66.34%154.35M

3,779.24%147.26M

Net cash flow

Beginning cash position

15.82%482.75M

-36.53%306.15M

-28.20%401.43M

89.31%559.11M

-14.56%397.21M

-10.19%416.82M

-6.90%482.38M

89.31%559.11M

10.55%295.35M

14.80%464.89M

Current changes in cash

-142.67%-47.33M

368.85%176.72M

-23.88%-95.06M

-159.79%-157.88M

-95.67%4.09M

-2,600.26%-19.5M

-21.69%-65.73M

-134.44%-76.73M

837.02%264.07M

186.25%94.53M

Effect of exchange rate changes

450.43%403K

-165.19%-118K

-10,850.00%-219K

161.24%188K

140.39%124K

---115K

--181K

---2K

---307K

End cash Position

9.72%435.83M

15.82%482.75M

-36.53%306.15M

-28.20%401.43M

-14.56%397.21M

-10.19%416.82M

-6.90%482.38M

89.31%559.11M

Free cash flow

13.51%-63.79M

-20.95%-86.4M

-38.52%-108.95M

-148.45%-300.33M

-45.08%-76.49M

-16.87%-73.75M

8.53%-71.44M

-207.68%-78.66M

39.07%-120.88M

19.65%-52.73M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	18.78%-59.23M	-21.87%-82.22M	-39.53%-102.3M	-244.55%-287.78M	-65.54%-74.08M	-33.70%-72.92M	-9.48%-67.47M	-194.74%-73.32M	47.34%-83.52M	26.83%-44.75M
Net income from continuing operations	-3.04%-95.84M	-27.13%-97.54M	-39.87%-91.37M	-36.99%-328.07M	-61.75%-93M	-53.89%-93.02M	-17.03%-76.73M	-16.70%-65.33M	-28.42%-239.48M	11.46%-57.49M
Depreciation and amortization	-5.01%7.2M	61.79%8.97M	97.88%7.38M	107.57%24.4M	135.00%7.55M	153.53%7.58M	98.96%5.54M	34.73%3.73M	39.87%11.76M	43.74%3.21M
Other non cash items	4,900.00%8.5M	-95.41%93K	-29.29%1.91M	33.76%11.45M	168.88%6.55M	-90.41%170K	-8.20%2.03M	26.12%2.7M	108.93%8.56M	110.54%2.44M
Change In working capital	159.75%2.67M	-1.41%-10.26M	-49.36%-36.45M	-147.90%-50.26M	-1,775.21%-11.27M	42.54%-4.46M	-6.12%-10.12M	-119.87%-24.4M	34,387.91%104.92M	84.82%-601K
-Change in receivables	-362.56%-939K	190.42%736K	-228.08%-1.04M	-387,700.00%-7.76M	-215.25%-6.42M	-105.37%-203K	54.78%-814K	95.80%-317K	99.96%-2K	306.72%5.57M
-Change in payables and accrued expense	-47.78%4.39M	-10.45%4.26M	-88.89%-17.96M	392.53%8.44M	-50.65%4.78M	131.91%8.41M	207.30%4.76M	27.67%-9.51M	-88.63%1.71M	442.35%9.69M
-Change in other current liabilities	-87.52%-4.7M	12.47%-2.62M	-55.24%-3.79M	-38.71%-9.86M	12.41%-1.91M	-18.58%-2.51M	-93.79%-3M	-93.20%-2.44M	---7.11M	---2.18M
-Change in other working capital	138.55%3.92M	-14.19%-12.64M	-12.54%-13.66M	-137.23%-41.08M	43.58%-7.72M	22.16%-10.16M	-43.01%-11.07M	-108.38%-12.13M	1,203.20%110.32M	-447.00%-13.68M
Cash from discontinued investing activities
Operating cash flow	18.78%-59.23M	-21.87%-82.22M	-39.53%-102.3M	-244.55%-287.78M	-65.54%-74.08M	-33.70%-72.92M	-9.48%-67.47M	-194.74%-73.32M	47.34%-83.52M	26.83%-44.75M
Investing cash flow
Cash flow from continuing investing activities	-1,214.70%-4.56M	-103.70%-4.18M	-24.59%-6.65M	-105.29%-10.23M	68.82%-2.49M	-100.65%-347K	-141.56%-2.05M	-103.73%-5.34M	171.11%193.25M	84.73%-7.98M
Net PPE purchase and sale	-512.35%-4.56M	70.21%-1.18M	-28.56%-6.65M	67.74%-11.96M	74.09%-2.07M	90.98%-745K	75.92%-3.97M	-19.18%-5.18M	6.88%-37.06M	-78.74%-7.98M
Net intangibles purchase and sale	--0	---3M	--0	-99.00%-597K	---350K	72.67%-82K	--0	---165K	---300K	--0
Net business purchase and sale	--0	----	----	--1.84M	---71K	--0	----	----	--0	--0
Net investment purchase and sale	----	----	----	-99.79%480K	--0	----	----	----	199.42%230.61M	--0
Cash from discontinued investing activities
Investing cash flow	-1,214.70%-4.56M	-103.70%-4.18M	-24.59%-6.65M	-105.29%-10.23M	68.82%-2.49M	-100.65%-347K	-141.56%-2.05M	-103.73%-5.34M	171.11%193.25M	84.73%-7.98M
Financing cash flow
Cash flow from continuing financing activities	-69.38%16.46M	6,848.03%263.12M	623.05%13.9M	-9.21%140.13M	-45.23%80.66M	2,200.60%53.77M	41.94%3.79M	-7.77%1.92M	-66.34%154.35M	3,779.24%147.26M
Net issuance payments of debt	-9,429.17%-2.29M	-8.33%-26K	-8.33%-26K	-751.11%-766K	-2,917.39%-694K	-4.35%-24K	-9.09%-24K	-9.09%-24K	99.30%-90K	-9.52%-23K
Net common stock issuance	-66.06%16.97M	--261.55M	--10.87M	-10.87%128.09M	-45.66%78.09M	--50M	--0	--0	-68.95%143.71M	--143.71M
Proceeds from stock option exercised by employees	-53.00%1.78M	-57.96%1.6M	56.73%3.05M	19.41%12.81M	-8.63%3.26M	60.55%3.79M	41.67%3.81M	-7.60%1.95M	27.11%10.72M	-6.52%3.57M
Cash from discontinued financing activities
Financing cash flow	-69.38%16.46M	6,848.03%263.12M	623.05%13.9M	-9.21%140.13M	-45.23%80.66M	2,200.60%53.77M	41.94%3.79M	-7.77%1.92M	-66.34%154.35M	3,779.24%147.26M
Net cash flow
Beginning cash position	15.82%482.75M	-36.53%306.15M	-28.20%401.43M	89.31%559.11M	-14.56%397.21M	-10.19%416.82M	-6.90%482.38M	89.31%559.11M	10.55%295.35M	14.80%464.89M
Current changes in cash	-142.67%-47.33M	368.85%176.72M	-23.88%-95.06M	-159.79%-157.88M	-95.67%4.09M	-2,600.26%-19.5M	-21.69%-65.73M	-134.44%-76.73M	837.02%264.07M	186.25%94.53M
Effect of exchange rate changes	450.43%403K	-165.19%-118K	-10,850.00%-219K	161.24%188K	140.39%124K	---115K	--181K	---2K	---307K	---307K
End cash Position	9.72%435.83M	15.82%482.75M	-36.53%306.15M	-28.20%401.43M	-28.20%401.43M	-14.56%397.21M	-10.19%416.82M	-6.90%482.38M	89.31%559.11M	89.31%559.11M
Free cash flow	13.51%-63.79M	-20.95%-86.4M	-38.52%-108.95M	-148.45%-300.33M	-45.08%-76.49M	-16.87%-73.75M	8.53%-71.44M	-207.68%-78.66M	39.07%-120.88M	19.65%-52.73M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--